Should I prescribe etoricoxib for an 80-year-old woman with mechanical lumbar pain that improves with movement?

Should You Prescribe Etoricoxib for This Patient?

No, you should not prescribe etoricoxib for this 80-year-old woman with mechanical lumbar pain. Instead, start with acetaminophen as first-line therapy, and if NSAIDs become necessary, use the lowest effective dose of a non-selective NSAID (such as ibuprofen or naproxen) with gastroprotection, while carefully weighing cardiovascular and renal risks.

Rationale Based on Guidelines

First-Line Therapy: Acetaminophen

Acetaminophen should be your initial pharmacologic choice for this elderly patient with mechanical low back pain 1. The 2009 JAGS guideline specifically recommends acetaminophen as first-line therapy for persistent pain in older adults due to its superior safety profile compared to NSAIDs—it lacks significant gastrointestinal bleeding risk, adverse renal effects, and cardiovascular toxicity 1.

For this patient:

• Start with 1000 mg three times daily (maximum 4 g/24 hours from all sources)
• Acetaminophen is effective for osteoarthritis and low back pain in older adults
• Educate the patient about total daily dose limits including over-the-counter sources

Why Not Etoricoxib in This Population?

Age-related contraindications are critical here. At 80 years old, this patient faces substantially elevated risks from COX-2 selective inhibitors:

1. Cardiovascular Risk: COX-2 inhibitors carry increased risk of myocardial infarction 1. The FDA labeling for meloxicam (a related COX-2 preferential NSAID) specifically warns about exercising caution in elderly patients 2.

2. Renal Concerns: NSAIDs adversely affect renal function, and elderly patients have age-related decline in glomerular filtration rate 1. The drug label explicitly states caution in renal impairment 2.

3. Gastrointestinal Toxicity: While COX-2 inhibitors have reduced GI bleeding compared to traditional NSAIDs, protection is not complete 1. GI toxicity increases in frequency and severity with age 1.

4. Limited Evidence Base: The 2017 ACP guideline found that NSAIDs had only small to moderate, primarily short-term effects on chronic low back pain 3. Recent systematic reviews confirm marked heterogeneity in NSAID recommendations for LBP 4.

Clinical Decision Algorithm

Step 1: Assess Pain Characteristics

• Mechanical pain that improves with movement suggests musculoskeletal rather than inflammatory etiology
• This pattern responds well to acetaminophen and activity modification

Step 2: Trial of Acetaminophen

• Start 1000 mg TID for 2-4 weeks
• Combine with staying active and therapeutic exercise (both strongly recommended for acute and chronic LBP) 3, 4

Step 3: If Acetaminophen Inadequate

Only if acetaminophen fails and pain significantly impacts function, consider:

• Non-selective NSAIDs (ibuprofen or naproxen) at lowest effective dose 1
• Mandatory gastroprotection with proton pump inhibitor 1
• Screen for contraindications:
  • Cardiovascular disease (especially recent MI, heart failure)
  • Chronic kidney disease (check creatinine clearance)
  • History of GI bleeding or peptic ulcer
  • Concurrent aspirin use (increases bleeding risk)
  • Uncontrolled hypertension

Step 4: Duration Limits

• NSAIDs should be used for shortest duration possible (typically <4 weeks) 3
• Reassess need at each visit

Common Pitfalls to Avoid

1. Don't assume COX-2 selectivity equals safety in elderly: The cardiovascular and renal risks remain significant 1.

2. Don't overlook polypharmacy: Check for drug interactions, especially with aspirin (which negates some COX-2 benefits) 1.

3. Don't ignore the evidence hierarchy: Guidelines consistently place acetaminophen before NSAIDs in elderly patients 1.

4. Don't prescribe long-term: The evidence shows primarily short-term benefits with accumulating risks over time 3.

Alternative Considerations

If pain persists despite acetaminophen:

• Duloxetine has modest evidence for chronic low back pain 3
• Therapeutic exercise and spinal manipulation are recommended across multiple guidelines 3, 4
• Consider referral to pain specialist if conservative measures fail

The risk-benefit ratio for etoricoxib in an 80-year-old does not favor its use when safer alternatives exist and should be exhausted first 1.